Literature DB >> 3360784

Transcriptional regulation of ceruloplasmin gene expression during inflammation.

J D Gitlin1.   

Abstract

Mixed sequence oligonucleotides were used to isolate a series of acute-phase human liver cDNA clones corresponding to the serum alpha 2-globulin ceruloplasmin. These clones were characterized, sequenced, and used to analyze changes in hepatic ceruloplasmin mRNA content during inflammation. In all species examined, hepatic ceruloplasmin mRNA content increased approximately 6-10-fold over control values within 24 h following the induction of inflammation. The mechanisms leading to this increase in hepatic ceruloplasmin mRNA content were studied following turpentine-induced inflammation in Syrian hamsters. Nuclear run-on assays demonstrated an increase in the relative rate of transcription of the ceruloplasmin gene within 3 h following induction, reaching maximum values by 18 h. Hepatic ceruloplasmin mRNA content increased 2-fold within 12 h following induction, reached maximum values by 24 h, and returned to control within 72 h. In contrast, serum ceruloplasmin concentration did not increase until 36 h, reached maximal levels by 120 h, and remained elevated for the course of the study. These data indicate that inflammation leads to a rapid increase in hepatic ceruloplasmin mRNA content. This increase is largely the result of increased ceruloplasmin gene transcription, but comparison of the relative rate of transcription and mRNA accumulation suggests that changes in ceruloplasmin mRNA turnover are also involved. In addition, translational and/or post-translational mechanisms must account for the observed changes in serum ceruloplasmin concentration seen during inflammation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360784

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Caeruloplasmin biosynthesis by the human uterus.

Authors:  M L Schilsky; R J Stockert; J W Pollard
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Ceruloplasmin gene expression in the murine central nervous system.

Authors:  L W Klomp; Z S Farhangrazi; L L Dugan; J D Gitlin
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.

Authors:  Seth Guller; Catalin S Buhimschi; Yula Y Ma; Se Te J Huang; Liubin Yang; Edward Kuczynski; Eduardo Zambrano; Charles J Lockwood; Irina A Buhimschi
Journal:  Lab Invest       Date:  2008-08-04       Impact factor: 5.662

4.  Serum protein profiling of adults and children with Crohn disease.

Authors:  Anna Vaiopoulou; Maria Gazouli; Aggeliki Papadopoulou; Athanassios K Anagnostopoulos; George Karamanolis; George E Theodoropoulos; Amosy M'Koma; George T Tsangaris
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

5.  Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease.

Authors:  Bakytzhan Bakhautdin; Maria Febbraio; Esen Goksoy; Carol A de la Motte; Muhammet F Gulen; Erin Patricia Childers; Stanley L Hazen; Xiaoxia Li; Paul L Fox
Journal:  Gut       Date:  2012-02-16       Impact factor: 23.059

6.  Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells.

Authors:  E Ehrenwald; P L Fox
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

7.  Delayed translational silencing of ceruloplasmin transcript in gamma interferon-activated U937 monocytic cells: role of the 3' untranslated region.

Authors:  B Mazumder; P L Fox
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

8.  Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Authors:  Z L Harris; Y Takahashi; H Miyajima; M Serizawa; R T MacGillivray; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Tissue-specific ceruloplasmin gene expression in the mammary gland.

Authors:  J L Jaeger; N Shimizu; J D Gitlin
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

10.  Serum paraoxonase, TAS, TOS and ceruloplasmin in brucellosis.

Authors:  Ozlem Demirpençe; Bünyamin Sevim; Mustafa Yıldırım; Nilhan Ayan Nurlu; Duygu Mert; Osman Evliyaoğlu
Journal:  Int J Clin Exp Med       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.